Qingdao Baheal Medical INC. (301015): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 23,39 Renminbi Yuan | 30,95 Renminbi Yuan | 18,4 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 27,31 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 525.624.077 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
Umsatz | 7.506.514,889 | 8.094.458,067 | 8.255.997,67 | 7.509.618,039 | 7.051.567,224 | 5.879.322,862 | 4.848.663,511 | 3.652.461,657 |
Cashflow aus operativer Geschäftstätigkeit | 934.453,605 | 813.850,404 | 799.495,015 | 305.753,768 | 181.296,527 | -116.834,538 | 45.960,933 | 55.503,555 |
▸ Operative Cashflow Marge | 12,45% | 10,05% | 9,68% | 4,07% | 2,57% | -1,99% | 0,95% | 1,52% |
Investitionsausgaben (CapEx) | 288.930,825 | 303.988,624 | 185.487,938 | 105.323,731 | 27.489,297 | 16.352,452 | 2.954,406 | 15.739,3 |
Cashflow aus Investitionstätigkeit | - | -732.318,723 | -295.706,858 | -117.326,325 | -22.823,485 | -42.627,298 | 701,264 | -69.978,289 |
Cashflow aus Finanzierungstätigkeit | - | 4.665,666 | -333.198,433 | -543.584,739 | 38.037,565 | 305.810,98 | 239.291,076 | -99.756,745 |
Freier Cashflow | 645.522,78 | 509.861,78 | 614.007,077 | 200.430,037 | 153.807,23 | -133.186,99 | 43.006,527 | 39.764,255 |
▸ Freie Cashflow Marge | 8,6% | 6,3% | 7,44% | 2,67% | 2,18% | -2,27% | 0,89% | 1,09% |
Ausgeschüttete Dividenden | -467.570,633 | -449.862,255 | -440.110,631 | -350.241,7 | -55.724,064 | -148.914,866 | -50.200,807 | - |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.